Pricing Log in Create free account

Altamira Therapeutics Ltd. (CYTOF) vs Moolec Science SA (MLEC)

Altamira Therapeutics Ltd. and Moolec Science SA are both Biotechnology companies. Moolec Science SA is the larger, with a market value of $1.4M against $1.1M — 1.2× the size. Altamira Therapeutics Ltd. has the higher net margin (0.00% vs −7.18%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, Moolec Science SA leads on 6 and Altamira Therapeutics Ltd. on 3.

Valuation

Metric CYTOF MLEC Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.00 9.71
P/B n/m 0.03 2.13
Price to free cash flow n/m 0.02 20.82
EV/EBITDA n/m 1.76 0.64
EV/Sales n/m 0.14 9.21
Earnings yield (44,544.44%) (4,665.32%) (33.15%)
Free cash flow yield (9,080,722.22%) 4,200.26% (25.50%)

Profitability

Metric CYTOF MLEC Biotechnology median
Gross margin 0.00% 39.67% 65.16%
Operating margin 0.00% 4.09% 0.00%
Net margin 0.00% (7.18%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (56.36%)
Return on assets 0.00% 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYTOF MLEC Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 81.52% (447.53%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYTOF MLEC Biotechnology median
Debt to equity 0.11 4.37 0.00
Current ratio 0.11 0.15 4.72
Net debt to EBITDA (0.27) (2.73) 0.96

Dividend

Metric CYTOF MLEC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYTOF MLEC Biotechnology median
Market cap 1.13m 1.36m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack